101 related articles for article (PubMed ID: 11561139)
1. Systemic chemotherapy with epirubicin for treatment of advanced or multifocal hepatocellular carcinoma.
Pohl J; Zuna I; Stremmel W; Rudi J
Chemotherapy; 2001; 47(5):359-65. PubMed ID: 11561139
[TBL] [Abstract][Full Text] [Related]
2. A phase II trial of transcatheter arterial infusion chemotherapy with an epirubicin-Lipiodol emulsion for advanced hepatocellular carcinoma refractory to transcatheter arterial embolization.
Tanaka T; Ikeda M; Okusaka T; Ueno H; Morizane C; Ogura T; Hagihara A; Iwasa S
Cancer Chemother Pharmacol; 2008 Apr; 61(4):683-8. PubMed ID: 17541589
[TBL] [Abstract][Full Text] [Related]
3. A phase II study of epirubicin and thalidomide in unresectable or metastatic hepatocellular carcinoma.
Zhu AX; Fuchs CS; Clark JW; Muzikansky A; Taylor K; Sheehan S; Tam K; Yung E; Kulke MH; Ryan DP
Oncologist; 2005; 10(6):392-8. PubMed ID: 15967833
[TBL] [Abstract][Full Text] [Related]
4. Phase II study with a combination of epirubicin, cisplatin, UFT, and leucovorin in advanced hepatocellular carcinoma.
Kim SJ; Seo HY; Choi JG; Sul HR; Sung HJ; Park KH; Choi IK; Oh SC; Yoon SY; Seo JH; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS
Cancer Chemother Pharmacol; 2006 Apr; 57(4):436-42. PubMed ID: 16049620
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy of hepatic arterial infusion therapy for advanced hepatocellular carcinoma using 5-fluorouracil, epirubicin and mitomycin-C].
Hwang JY; Jang BK; Kwon KM; Chung WJ; Park KS; Cho KB; Hwang JS; Ahn SH; Kim GC; Kim YH; Choi JS; Kwon JH
Korean J Gastroenterol; 2005 Feb; 45(2):118-24. PubMed ID: 15725716
[TBL] [Abstract][Full Text] [Related]
6. Hepatic arterial infusion chemotherapy with epirubicin in patients with advanced hepatocellular carcinoma and portal vein tumor thrombosis.
Ikeda M; Okusaka T; Ueno H; Morizane C; Iwasa S; Hagihara A; Kojima Y
Oncology; 2007; 72(3-4):188-93. PubMed ID: 18097170
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic efficacy of multimodal combination therapy using transcatheter arterial infusion of epirubicin and cisplatin, systemic infusion of 5-fluorouracil, and additional percutaneous ethanol injection for unresectable hepatocellular carcinoma.
Jang JW; Park YM; Bae SH; Choi JY; Yoon SK; Chang UI; Nam SW; Kim BS
Cancer Chemother Pharmacol; 2004 Nov; 54(5):415-20. PubMed ID: 15235823
[TBL] [Abstract][Full Text] [Related]
8. Discordant influence of amphotericin B on epirubicin cytotoxicity in primary hepatic malignant cells collected by a new primary culture technique.
Lin ZY; Chuang WL; Chuang YH; Yu ML; Hsieh MY; Wang LY; Tsai JF
J Gastroenterol Hepatol; 2006 Feb; 21(2):398-405. PubMed ID: 16509865
[TBL] [Abstract][Full Text] [Related]
9. Size of lipid microdroplets effects results of hepatic arterial chemotherapy with an anticancer agent in water-in-oil-in-water emulsion to hepatocellular carcinoma.
Higashi S; Tabata N; Kondo KH; Maeda Y; Shimizu M; Nakashima T; Setoguchi T
J Pharmacol Exp Ther; 1999 May; 289(2):816-9. PubMed ID: 10215657
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of epirubicin and etoposide combination chemotherapy in advanced hepatocellular carcinoma: a retrospective analysis.
Lee JL; Ryu MH; Chang HM; Kim TW; Lee SS; Sym SJ; Kim MK; Kim KM; Lee JS; Kang YK
J Gastroenterol Hepatol; 2008 May; 23(5):811-6. PubMed ID: 17995941
[TBL] [Abstract][Full Text] [Related]
11. Arterial-injection chemotherapy for hepatocellular carcinoma using monodispersed poppy-seed oil microdroplets containing fine aqueous vesicles of epirubicin. Initial medical application of a membrane-emulsification technique.
Higashi S; Shimizu M; Nakashima T; Iwata K; Uchiyama F; Tateno S; Tamura S; Setoguchi T
Cancer; 1995 Mar; 75(6):1245-54. PubMed ID: 7882276
[TBL] [Abstract][Full Text] [Related]
12. 4'Epidoxorubicin (epirubicin): activity in hepatocellular carcinoma.
Hochster HS; Green MD; Speyer J; Fazzini E; Blum R; Muggia FM
J Clin Oncol; 1985 Nov; 3(11):1535-40. PubMed ID: 2997408
[TBL] [Abstract][Full Text] [Related]
13. Treatment of hepatocellular carcinoma (HCC) with systemic chemotherapy combining epirubicin, cisplatinum and infusional 5-fluorouracil (ECF regimen).
Boucher E; Corbinais S; Brissot P; Boudjema K; Raoul JL
Cancer Chemother Pharmacol; 2002 Oct; 50(4):305-8. PubMed ID: 12357305
[TBL] [Abstract][Full Text] [Related]
14. New utility of an old marker: serial alpha-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic chemotherapy.
Chan SL; Mo FK; Johnson PJ; Hui EP; Ma BB; Ho WM; Lam KC; Chan AT; Mok TS; Yeo W
J Clin Oncol; 2009 Jan; 27(3):446-52. PubMed ID: 19064965
[TBL] [Abstract][Full Text] [Related]
15. A combination therapy with transarterial chemo-lipiodolization and systemic chemo-infusion for large extensive hepatocellular carcinoma invading portal vein in comparison with conservative management.
Jang JW; Bae SH; Choi JY; Oh HJ; Kim MS; Lee SY; Kim CW; Chang UI; Nam SW; Cha SB; Lee YJ; Chun HJ; Choi BG; Byun JY; Yoon SK
Cancer Chemother Pharmacol; 2007 Jan; 59(1):9-15. PubMed ID: 16614848
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of doxorubicin and cisplatin in patients with metastatic hepatocellular carcinoma.
Lee J; Park JO; Kim WS; Park SH; Park KW; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC; Joh J; Kim K; Jung CW; Park YS; Im YH; Kang WK; Lee MH; Park K
Cancer Chemother Pharmacol; 2004 Nov; 54(5):385-90. PubMed ID: 15248028
[TBL] [Abstract][Full Text] [Related]
17. Transarterial infusion chemotherapy with epirubicin in water-in-oil-in-water emulsion for recurrent hepatocellular carcinoma in the residual liver after hepatectomy.
Ikushima I; Higashi S; Seguchi K; Ishii A; Ota Y; Shima M; Kanemaru M; Hidaka Y
Eur J Radiol; 2009 Jan; 69(1):114-9. PubMed ID: 17935921
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the mRECIST and α-fetoprotein ratio for stratification of the prognosis of advanced-hepatocellular-carcinoma patients treated with sorafenib.
Kawaoka T; Aikata H; Murakami E; Nakahara T; Naeshiro N; Tanaka M; Honda Y; Miyaki D; Nagaoki Y; Takaki S; Hiramatsu A; Waki K; Takahashi S; Chayama K
Oncology; 2012; 83(4):192-200. PubMed ID: 22890083
[TBL] [Abstract][Full Text] [Related]
19. No synergistic activity of epirubicin and interferon-alpha 2b in the treatment of hepatocellular carcinoma.
Bokemeyer C; Kynast B; Harstrick A; Laage E; Schmoll E; von Wussow P; Schmoll HJ
Cancer Chemother Pharmacol; 1995; 35(4):334-8. PubMed ID: 7828277
[TBL] [Abstract][Full Text] [Related]
20. Treatment for advanced hepatocellular carcinoma by transarterial chemotherapy using reservoirs or one-shot arterial chemotherapy.
Sakai Y; Izumi N; Tazawa J; Yoshida T; Sakai H; Yauchi T; Hattori K; Tozuka S; Marumo F; Sato C
J Chemother; 1997 Oct; 9(5):347-51. PubMed ID: 9373790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
